Literature DB >> 32858150

Effects of RU486 treatment after single prolonged stress depend on the post-stress interval.

Jinlan Ding1, Xinzhao Chen2, Marcia Santos da Silva3, Jolanthe Lingeman3, Fang Han4, Onno C Meijer5.   

Abstract

The Single Prolonged Stress protocol is considered a model for PTSD, as it induces long lasting changes in rat behaviour and endocrine regulation. Previous work demonstrated that some of these changes can be prevented by treatment with the glucocorticoid receptor antagonist RU486, administered a week after the stressor. The current study evaluated the effects of an earlier intervention with RU486, as evaluated 1 week after SPS-exposure. Most RU486 effects occurred independent of prior stress, except for the reversal of a stress-induced increase in locomotor behaviour. The accompanying changes in gene expression depended on gene, brain region, and time. DNA methylation of the robustly down-regulated Fkbp5 gene was dissociated of changes in mRNA expression. The findings reinforce the long term effects of GR antagonist treatment, but also emphasize the need to evaluate changes over time to allow the identification of robust correlates between gene expression and behavioural/endocrine outcome of stressful experiences.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behaviour; FKBP5; Mifepristone; Sgk1; Single prolonged stress

Mesh:

Substances:

Year:  2020        PMID: 32858150     DOI: 10.1016/j.mcn.2020.103541

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  2 in total

1.  Effects of RU486 in Treatment of Traumatic Stress-Induced Glucocorticoid Dysregulation and Fear-Related Abnormalities: Early versus Late Intervention.

Authors:  Chen-Cheng Lin; Pao-Yun Cheng; Michael Hsiao; Yia-Ping Liu
Journal:  Int J Mol Sci       Date:  2022-05-14       Impact factor: 6.208

Review 2.  Pharmacological Implications of Adjusting Abnormal Fear Memory: Towards the Treatment of Post-Traumatic Stress Disorder.

Authors:  Chen-Cheng Lin; Yia-Ping Liu
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.